We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Get fresh ideas in forensics! Attend ISHI 28.

PowerPlex® 16 System

Multiplex STR System for use in DNA Typing

  • Amplify all 13 CODIS STR loci in one reaction
  • Analyze minute quantities of DNA
  • Size standard, amplification-grade water and master mix are included

Size

Catalog number selected: DC6531

$ 2,769.00 Your price: Log In

Add to Helix Add to Helix
PowerPlex® 16 System
100 reactions
$ 2,769.00
Your price: Log In
Change Configuration

The PowerPlex® 16 System is a multiplex STR system for use in DNA typing, including paternity testing, forensic DNA analysis, human identity testing and tissue culture strain identification. This system allows co-amplification and three-color detection of sixteen loci (fifteen STR loci and Amelogenin): Penta E, D18S51, D21S11, TH01, D3S1358, FGA, TPOX, D8S1179, vWA, Amelogenin, Penta D, CSF1PO, D16S539, D7S820, D13S317 and D5S818. One primer for each of the Penta E, D18S51, D21S11, TH01 and D3S1358 loci is labeled with fluorescein (FL); one primer for each of the FGA, TPOX, D8S1179, vWA and Amelogenin loci is labeled with carboxy-tetramethylrhodamine (TMR); and one primer for each of the Penta D, CSF1PO, D16S539, D7S820, D13S317 and D5S818 loci is labeled with 6-carboxy-4´,5´-dichloro-2´,7´-dimethoxy-fluorescein (JOE). All sixteen loci are amplified simultaneously in a single tube and analyzed in a single injection or gel lane.

The PowerPlex® 16 System has undergone extensive validation efforts including internal validation, CODIS database validation and forensic casework validation. This system is optimized for use with 1ng of DNA; however, each lot performance tested to provide reproducible results with 0.5ng of DNA. Additional studies show interpretable results can be obtained with <0.5ng of DNA. The Internal Lane Standard 500 marker is used in each gel lane or capillary injection to increase the precision of analysis and allelic ladders for all 16 loci are provided to simplify interpretation. Panels and bins text files are required for use with GeneMapper® ID and GeneMapper® ID-X software and are available for download. 

The PowerPlex® 16 System is compatible with the ABI PRISM® 310, 3100 and 3100-Avant Genetic Analyzers and Applied Biosystems 3130 and 3130xl Genetic Analyzers. The PowerPlex® Matrix Standards, 310 (Cat.# DG4640), is required for use of this system with the ABI PRISM® 310 Genetic Analyzer. The PowerPlex® 4C Matrix Standard (Cat.# DG4800) is required for use of this system with the ABI PRISM® 3100 and 3100-Avant and Applied Biosystems 3130 and 3130xl Genetic Analyzers.

Rapid Processing Solutions for PowerPlex®

The 5X AmpSolution™ Reagent, SwabSolution™ Kit and PunchSolution™ Kit allow fast and simple processing of swabs and punches for analysis with various PowerPlex® Systems, including the PowerPlex® Fusion, 21, 18D, 16 HS, ESX, ESI, CS7 and Y23 Systems. These products are intended for preparation of single-source reference, database and paternity samples where sample purification is unnecessary.

Which Product is Right for Me?

Take me to the Product Selector

Protocols

Specifications

You are viewing: DC6531 Change Configuration

What's in the box?

Item Part # SizeConcentrationAvailable Separately

2800M Control DNA

DD710A 1 x 25μl10ng/μl View Product

Internal Lane Standard 600

DG107A 1 x 150μl View Product

PowerPlex® 16 Allelic Ladder Mix

DG600B 1 x 50μl

PowerPlex® 16 10X Primer Pair Mix

DK711B 1 x 250μl

Gold ST★R 10X Buffer

DM241C 1 x 300μl

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

Not For Medical Diagnostic Use.

Storage Conditions

BB

Patents and Disclaimers

U.S. Pat. No. 6,238,863 and other patents and patents pending.

Australian Pat. No. 724531, Canadian Pat. No. 2,251,793 and other patents and patents pending.

The purchase of this product does not convey a license to use AmpliTaq Gold® DNA polymerase. You should purchase AmpliTaq Gold® DNA polymerase licensed for the forensic and human identity field directly from your authorized enzyme supplier.

Allele sequences for one or more of the loci vWA, FGA, D8S1179, D21S11 and D18S51 in allelic ladder mixtures is licensed under U.S. Pat. Nos. 7,087,380 and 7,645,580, Australia Pat. No. 2003200444 and corresponding patent claims outside the US.

Specifications

You are viewing: DC6530 Change Configuration

What's in the box?

Item Part # SizeConcentrationAvailable Separately

2800M Control DNA

DD710A 1 x 25μl10ng/μl View Product

Internal Lane Standard 600

DG107A 4 x 150μl View Product

PowerPlex® 16 Allelic Ladder Mix

DG600B 4 x 50μl

PowerPlex® 16 10X Primer Pair Mix

DK711B 4 x 250μl

Gold ST★R 10X Buffer

DM241C 4 x 300μl

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
No results
Loading…

Use Restrictions

Not For Medical Diagnostic Use.

Storage Conditions

BB

Patents and Disclaimers

U.S. Pat. No. 6,238,863 and other patents and patents pending.

Australian Pat. No. 724531, Canadian Pat. No. 2,251,793 and other patents and patents pending.

The purchase of this product does not convey a license to use AmpliTaq Gold® DNA polymerase. You should purchase AmpliTaq Gold® DNA polymerase licensed for the forensic and human identity field directly from your authorized enzyme supplier.

Allele sequences for one or more of the loci vWA, FGA, D8S1179, D21S11 and D18S51 in allelic ladder mixtures is licensed under U.S. Pat. Nos. 7,087,380 and 7,645,580, Australia Pat. No. 2003200444 and corresponding patent claims outside the US.

Resources

workflow-background

Genetic Identity Workflow

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom